{"name":"TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)","slug":"theras-inc-d-b-a-bbot-bridgebio-oncology-therapeutics","ticker":"","exchange":"","domain":"","description":"BBOT (BridgeBio Oncology Therapeutics), a subsidiary of TheRas, Inc., is a biotechnology company focused on developing innovative therapies for patients with cancer. The company's pipeline includes three drug candidates, all currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOdm5VNTNMUEZwSU1lMENqYkZLMzNpSC1Qdml5bTNUbjFTQS1oNF92RHUwdEpzV3UxLTRmaWtPWk5tdGlid0ZiQkctVVFrUXhiXzVxeUl3dWM4VUVuODY3RjhPbTgwRTZwdWpGWVUwSTdCOERoVDhReWpHczh1dHFrUUllUkpnRnU0T01wRkRSdXcxZXVCVDZ0UG02Y1lqLTdscXZuM0ZBU3I3aXNadWtDSURmRUEzWnZnekp3SDEwR3ZXQWts?oc=5","date":"2025-07-21","type":"pipeline","source":"Business Wire","summary":"BBOT Appoints Industry Veteran Uneek Mehra as Chief Financial Officer - Business Wire","headline":"BBOT Appoints Industry Veteran Uneek Mehra as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQdVlfbFkwcGR1OXVTd0tlT3piLXV5eG4zRTNTRmxhQ3U1VF94b0lxUFhRSlF2Y0ZjTjRHZDBTRE0yc1FzU3BqaGxyaWVHeDA5Zmpta3FWd3pWdV9vQzZ3cmZaaFZMZjJ2YVY0cktHcmJRdnRuQzJzVElqa3ZDTXhDeHpuX3I0SlJBZ3dVdHUxQmFuUk15ektqYmhoV1NVMGFLQTV5NW1lTFJWVFhlWGNnQmdDckctdkF4?oc=5","date":"2025-07-11","type":"deal","source":"Stock Titan","summary":"BridgeBio Oncology's SPAC Merger Advances: SEC Clears Path for Novel Cancer Drug Development Platform - Stock Titan","headline":"BridgeBio Oncology's SPAC Merger Advances: SEC Clears Path for Novel Cancer Drug Development Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxOOHNvSzVDZjFZREktb0hEVnp4SW40WXpycHpSVy1OcjRtdGZTWTJOdXhjLVpvVHNXa21fMnZpczhBbTQ2LWdaTlk0dkFOaW1GUHFvUUxpeVV4NExEUW4tRnZlUUpfMXZVQ0RTUFpQNXFrZXhWNUxoNTRQQjBvT19ZMjVnVW0tUkh0Qi03NXRfLUNodUFKMDZQM2lGamhkWTFoXy0tcDBXOThFaXQxdlB4Tl94ZjhGUWo3Yy05OVFHa09tcXZhOGdCTjdxa2o5T2ViRV94b21hUUI2MEFSTnVEZHROSHZtekcyZHVidDdQQjZDX2N5U0V4RE9GNjlsY1puaVBPTjJjZDRMNkpOdjJzOFVzRm12MXVQRkE?oc=5","date":"2025-04-01","type":"trial","source":"Business Wire","summary":"BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors - Business Wire","headline":"BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advance","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-03","type":"pipeline","source":"BioSpace","summary":"BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targ","headline":"BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPSGdxa2s5bWFUUFRKTHkwQzNyNnVvZDFHaGc5R0lHMzZOZ3VBaXdseVpwcGQ3TDdrVG1qRGRhYzdBOUJJSmNjcGYxRTYzbXJONXBPTXB1RUNuQjVXZU1fQ2lYOVA2cVdZV1pNLTBxYmRMSl92bm9hYnJsYk80YS1LeW5UYnBMcU9IN28zTjJFQm9FOTltOUk1akhCVzdHb2ZxRFFJSktnemVvTGFpV1E?oc=5","date":"2025-02-28","type":"pipeline","source":"citybiz","summary":"BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II To Merge - citybiz","headline":"BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II To Merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOZDBVaEtra19HOHZfdE1fMEk4NXVKRDM5VWx0Q1NqUEk5bUxtZXVjbXJ1YW9pSzRmTFF4SnRqVXhxZEdINWE4T0RJZ0wzUjBIcUpFRmVvcHBod043ZWFwTUttZ1hCM19GblQzdDBWeG5YSTYxeExzVHBOT2E3WUp0bG03Zndkc05HMmQ3eE9RWlA0VG9lUFZ1WXM1TUo0UHZlcmxkbHFlOUxRQXc3bDJjcnhyd19yaVo4U3gwV3dQT2ZfWmpQMHdiOURCUmtGaUZ1ekdyMDRDZ1hQM2RidWFaZE4yYmNOUU1kVko1ZW9EalExeGJNZ1FlZU1ZekN2cEtHMF8yc2dQV2tVTW5TTW1fXzRHWjlYS0NIcVI4amxsb1A4SWFjd2hBcHhpTDQ2dw?oc=5","date":"2025-01-09","type":"regulatory","source":"Business Wire","summary":"BridgeBio Oncology Therapeutics (BBOT) Granted U.S. FDA Fast Track Designation for BBO-8520 for KRAS - Business Wire","headline":"BridgeBio Oncology Therapeutics (BBOT) Granted U.S. FDA Fast Track Designation for BBO-8520 for KRAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNWnNSVFNZNktXQzN3amFCWjREWHRvWVR2bG1kcGQ2M2dBbHN4anFwa0g4dnpVMFQ0NndxQzdfaHQ4cEphNmUzVHRyU2VwTmtLVzAyZ3dFaWtTOUpHWjhWVWxzNGZCc2RyMzNMTmRFWW5lckcxblZhWnRGZG5fbFZ5cmlZeGlsMFJVTHBSbkxUNEdiZE5xT21EeFQwZERYNmVQc3ZUcV9IVVNLQUJfdF8wWVQ4NDROT3ZYX2lCVkgzWkVLT2xJdHlRWHh0M01NWVZvR1FXZWJFZTIxcThEX0kxdEs2bl8zRGRSamtaWk85bw?oc=5","date":"2024-11-18","type":"pipeline","source":"BioSpace","summary":"BridgeBio Oncology Therapeutics (BBOT) Appoints Praveen Tipirneni, MD, to its Board of Directors as Non-Executive Director - BioSpace","headline":"BridgeBio Oncology Therapeutics (BBOT) Appoints Praveen Tipirneni, MD, to its Board of Directors as Non-Executive Direct","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPTXlIX1NhRmMtd2RMNkl0RFp5MEd4RWJ3Mjl0WFdoM29TVVBWX0lqV0hDeWlkUEk4NUs3Z2o5TFB4amY1bEpScDBNbFVCclBkR2NNUUxaNTNGMWhzZkNwczVmTzV6SWtPRkowaThnZWIxenkzWGR5MmlDRmFSMjIxTHhNVHlsbkd3T3ZKMkFxbmhCS1F5MnhvRGswb0VKT0Y3VVNwSTV5WHZWcUdaT01KZ0tkeWlwNlRTNExmX2I4alFIU0xxRlZlWmltYlctOUFsTC1acEVKN1NJVjZVZUk2blQxNFB1dVhZOEE5ZE1TUG9BYzYxZjRXV19WQ1RrR1kzTFNXcTl3?oc=5","date":"2024-09-09","type":"pipeline","source":"Business Wire","summary":"BridgeBio Oncology Therapeutics (BBOT) Announces the Appointment of Yong Ben, MD, as Chief Medical and Development Officer - Business Wire","headline":"BridgeBio Oncology Therapeutics (BBOT) Announces the Appointment of Yong Ben, MD, as Chief Medical and Development Offic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxQYldpbjFwR05QbXVNaWtMRFdxLWJJaWw2dzZuQkdVRlloMW5zLXI4OEpyRXkwU1Q1Z1VjNmZpZl9GN3lLOWlBck5ieXlKd1M3WHdIRDFvVkwtOXI5QXY2bkpIcm52Wmdpdnd6bjZyNVpXYkhSenZybUM4R0RMV3NSMkhxWkVaU0tzLU5vRThOcVlocGhlb2tqdFNnNmdYSjA1blcySmNHR0N2cDdLU0tQN1dieGhqdWhleWNRY2RBRVE2QzVfR2xJcVVLRDI5Q0ZZMXJ1OWlybFJRLU5hcFl0dDc2N3NZbWNvQ3VmRmlkdUpHd0IzRWV5SXc2WHRWbFV1SU55QkFsbFVZRmdpdy1CM1lUbkViVy14THhyTGVzOW16RkFuOUpNRWl3azIyYzE1dHZKT2Z2aGlzOUhLd0g1MWlCYVF6dV9pWFFkdU5faWowYVlGQ2E0?oc=5","date":"2024-05-02","type":"pipeline","source":"GlobeNewswire","summary":"BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) - GlobeNewswire","headline":"BridgeBio launches BridgeBio Oncology Therapeutics (BBOT)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}